Cynatine® FLX (Solubilized Keratin — Roxlor)

Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

Cynatine® FLX is a solubilized, bioavailable keratin from Roxlor, formulated for joint support. Keratin is a sulfur-rich structural protein, and the solubilized form has one small, industry-supported randomized trial in knee osteoarthritis reporting reduced pain and stiffness.

Studied Dose About 500 mg per day.
Active Compound Solubilized keratin (Cynatine FLX), a bioavailable form of the sulfur-rich structural protein of hair, nails and skin. It is not a structural component of joint cartilage, which is built from collagen and proteoglycans.

Benefits

Joint comfort and stiffness

In one randomized, placebo-controlled trial of 50 adults with knee osteoarthritis, 500 mg per day for 60 days reduced pain scores about twice as much as placebo and reduced stiffness. Flexibility and range of motion were not measured.

Sulfur amino acids (unproven for joints)

Keratin is a sulfur-rich structural protein of hair, nails and skin, not of cartilage, which is built from collagen and proteoglycans. Any contribution of its sulfur amino acids to joint or cartilage structure is an unproven mechanism and was not measured in the trial.

Antioxidant sulfur support (unproven)

Whether the sulfur in keratin affects antioxidant systems or joint oxidative stress is an unproven mechanism. No antioxidant or oxidative-stress outcome was measured in the trial.

Mechanism of action

1

Sulfur amino acid delivery

Solubilized keratin provides bioavailable cysteine and other sulfur amino acids used to build and maintain connective tissue and antioxidant molecules.

2

Proposed anti-inflammatory action (not measured)

The trial did not measure inflammatory markers, so any anti-inflammatory action is a proposed mechanism rather than a demonstrated effect.

Clinical trials

1
Solubilized Keratin (Cynatine FLX) for Knee Osteoarthritis Symptoms: single RCT, n=50
PubMed

Randomized, double-blind, placebo-controlled trial of solubilized keratin (Cynatine FLX) for symptoms of knee osteoarthritis. (Beer et al. 2013, Journal of Dietary Supplements)

50 adults with knee osteoarthritis (25 active, 25 placebo).

Over 60 days at 500 mg per day, pain scores fell about twice as much as placebo and stiffness was reduced. Flexibility and range of motion were not reported. This is the only trial and it was industry supported.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated — adverse events in the trial were minimal.
Mild digestive upset is occasionally reported.
No known major safety concerns at studied doses.

Important Drug interactions

No significant drug interactions are established.
Generally compatible with other joint supplements.
Tell your doctor if you take medication for arthritis.

Frequently asked questions about Cynatine® FLX (Solubilized Keratin — Roxlor)

What is Cynatine FLX?

Cynatine® FLX is a solubilized, bioavailable keratin from Roxlor, formulated for joint support. Keratin is a sulfur-rich structural protein, and the solubilized form has one small, industry-supported randomized trial in knee osteoarthritis reporting reduced pain and stiffness.

What is Cynatine FLX used for?

Cynatine FLX is researched primarily for Joint Health. In one randomized, placebo-controlled trial of 50 adults with knee osteoarthritis, 500 mg per day for 60 days reduced pain scores about twice as much as placebo and reduced stiffness. Flexibility and range of motion were not measured.

What is the recommended dosage of Cynatine FLX?

The clinically studied dose is About 500 mg per day. Always follow the product label and check with a healthcare provider for personal advice.

Is Cynatine FLX safe, and does it have side effects?

For most healthy adults, Cynatine FLX is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — adverse events in the trial were minimal. Mild digestive upset is occasionally reported. It may also interact with some medications. Cynatine FLX is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Cynatine FLX interact with any medications?

Possible interactions include: No significant drug interactions are established. Generally compatible with other joint supplements. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Cynatine FLX?

NutraSmarts rates the evidence for Cynatine FLX as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Beer C, Wood S, Veghte RH. A randomized, double-blind, placebo-controlled clinical trial to investigate the effect of Cynatine® FLX on symptoms of osteoarthritis. J Diet Suppl. 2013;10(3):184-94..PubMedUsed to support: In a single industry-supported randomized trial of 50 adults with knee osteoarthritis, 500 mg per day for 60 days reduced WOMAC pain scores about twice as much as placebo and reduced stiffness. Range of motion and flexibility were not reported outcomes.